• 2013

Company Description

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to treat herpes zoster disease.

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to treat herpes zoster disease. The company was founded in 2013 and is based in New York, New York. ContraVir Pharmaceuticals, Inc. operates as a subsidiary of Synergy Pharmaceuticals, Inc.